InnovAge Holding CorpNASDAQ:INNV
- LAST PRICE4.8900
- TODAY'S CHANGE (%)0.2600 (5.6156%)
- Bid / Lots4.6400/ 1
- Ask / Lots7.7700/ 2
- Open / Previous Close4.6700 / 4.6300
- Day Range
- 52 Week Range
- Volume64,192
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | INNV |
|---|---|---|
| 09:32 ET | 404 | 4.69 |
| 09:48 ET | 100 | 4.67 |
| 10:06 ET | 100 | 4.735 |
| 10:11 ET | 215 | 4.735 |
| 10:40 ET | 116 | 4.745 |
| 10:49 ET | 104 | 4.745 |
| 10:51 ET | 300 | 4.735 |
| 11:03 ET | 115 | 4.74 |
| 11:07 ET | 115 | 4.74 |
| 11:18 ET | 100 | 4.735 |
| 11:30 ET | 261 | 4.75 |
| 11:32 ET | 921 | 4.77 |
| 11:34 ET | 2897 | 4.745 |
| 11:39 ET | 6134 | 4.73 |
| 11:45 ET | 875 | 4.86 |
| 11:56 ET | 100 | 4.79 |
| 12:14 ET | 100 | 4.81 |
| 12:32 ET | 100 | 4.795 |
| 12:33 ET | 200 | 4.79 |
| 12:35 ET | 100 | 4.86 |
| 12:48 ET | 500 | 4.783 |
| 12:50 ET | 600 | 4.705 |
| 01:54 ET | 900 | 4.75 |
| 01:56 ET | 200 | 4.75 |
| 02:05 ET | 100 | 4.77 |
| 02:16 ET | 100 | 4.8 |
| 02:18 ET | 8336 | 4.88 |
| 02:43 ET | 600 | 4.96 |
| 02:45 ET | 18900 | 4.98 |
| 02:52 ET | 100 | 5.005 |
| 03:15 ET | 467 | 4.98 |
| 03:24 ET | 300 | 4.85 |
| 03:33 ET | 800 | 4.77 |
| 03:35 ET | 300 | 4.755 |
| 03:42 ET | 530 | 4.785 |
| 03:50 ET | 600 | 4.85 |
| 03:51 ET | 100 | 4.835 |
| 03:55 ET | 700 | 4.86 |
| 03:57 ET | 165 | 4.86 |
| 04:00 ET | 7671 | 4.89 |
Nov 5, 2024
InnovAge Announces Financial Results for the Fiscal First Quarter Ended September 30, 2024, from 4:05PM ET on Tuesday Nov 05, 2024 by Dow Jones
4:05PM ET on Tuesday Nov 05, 2024 by Dow JonesPress Release: InnovAge Announces Financial Results for the Fiscal First Quarter Ended September 30, 2024, from 4:05PM ET on Tuesday Nov 05, 2024 by Dow Jones
4:05PM ET on Tuesday Nov 05, 2024 by Dow Jones
Nov 4, 2024
Press Release: InnovAge Appoints Michael Scarbrough as New President and Chief Operating Officer and Maria Lozzano as President, Pharmacy Services, from 8:00AM ET on Monday Nov 04, 2024 by Dow Jones
8:00AM ET on Monday Nov 04, 2024 by Dow JonesInnovAge Appoints Michael Scarbrough as New President and Chief Operating Officer and Maria Lozzano as President, Pharmacy Services, from 8:00AM ET on Monday Nov 04, 2024 by Dow Jones
8:00AM ET on Monday Nov 04, 2024 by Dow Jones
Nov 1, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
InnovAge Holding Corp | 627.3M | -41.6x | --- |
Extendicare Inc | 617.8M | 16.3x | +37.33% |
DocGo Inc | 420.4M | 15.0x | --- |
Global Medical REIT Inc | 583.2M | -405.8x | -8.35% |
Diversified Healthcare Trust | 588.7M | -1.5x | --- |
Fulgent Genetics Inc | 518.4M | -3.2x | --- |
Company Information
InnovAge Holding Corp. is a healthcare delivery platform. The Company is focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. The Company's programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its Program of All-Inclusive Care for the Elderly (PACE) program, it fulfills a range of medical and ancillary services for seniors, including in-home care services (skilled, unskilled and personal care), center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center and third-party medical appointments; and care management. Its participant-centered approach is led by the Company's Interdisciplinary Care Teams (IDTs), who oversee all aspects of each participant’s care plan.
Contact Information
- Headquarters
- 8950 E. Lowry BoulevardDENVER, CO, United States 80230
- Phone
- 303-869-4664
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- James Carlson
- President, Chief Operating Officer
- Michael Scarbrough
- Chief Executive Officer
- Patrick Blair
- Chief Financial Officer
- Benjamin Adams
- Chief Medical Officer
- Richard Feifer
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $627.3M |
|---|---|
Revenue (TTM) | $786.5M |
Shares Outstanding | 135.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.32 |
EPS | $-0.12 |
Book Value | $1.98 |
P/E Ratio | -41.6x |
Price/Sales (TTM) | 0.8 |
Price/Cash Flow (TTM) | 279.9x |
Operating Margin | -2.21% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
